Form 4 for LUNG Pulmonx Corp
Accepted 2026-03-04 00:00:00 ET · period of report 2026-03-02 · accession 0001805624-26-000001 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-04 | 2026-03-02 | LUNG | French Glendon E. III | Pres, CEO, Dir | S - Sale | $1.43 | -67.8K | 1.47M | -4% | -$97.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-02 | S | D | 58,368 | $1.43 | 1,409,511 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-02 | S | D | 2,708 | $1.43 | 1,474,616 | D | — | — | |
| 3 | Common | Common Stock | 2026-03-02 | S | D | 6,737 | $1.43 | 1,467,879 | D | — | — |